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Abstract
Cardiac Na
+ channels encoded by the SCN5A gene are essential for initiating heart beats and maintaining a regular heart
rhythm. Mutations in these channels have recently been associated with atrial fibrillation, ventricular arrhythmias,
conduction disorders, and dilated cardiomyopathy (DCM). We investigated a young male patient with a mixed phenotype
composed of documented conduction disorder, atrial flutter, and ventricular tachycardia associated with DCM. Further
family screening revealed DCM in the patient’s mother and sister and in three of the mother’s sisters. Because of the
complex clinical phenotypes, we screened SCN5A and identified a novel mutation, R219H, which is located on a highly
conserved region on the fourth helix of the voltage sensor domain of Nav1.5. Three family members with DCM carried the
R219H mutation. The wild-type (WT) and mutant Na
+ channels were expressed in a heterologous expression system, and
intracellular pH (pHi) was measured using a pH-sensitive electrode. The biophysical characterization of the mutant channel
revealed an unexpected selective proton leak with no effect on its biophysical properties. The H
+ leak through the mutated
Nav1.5 channel was not related to the Na
+ permeation pathway but occurred through an alternative pore, most probably a
proton wire on the voltage sensor domain. We propose that acidification of cardiac myocytes and/or downstream events
may cause the DCM phenotype and other electrical problems in affected family members. The identification of this clinically
significant H
+ leak may lead to the development of more targeted treatments.
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Introduction
The SCN5A gene codes for the a subunit of the human cardiac
voltage-gated Na
+ channel (Nav1.5) [1]. The most common
phenotypes of SCN5A mutations are long QT syndrome type 3
(LQT3) [2] and Brugada syndrome (BrS) [3,4], which can lead to
malignant ventricular arrhythmias and sudden death [5]. Both
syndromes are diagnosed on surface ECGs. The various clinical
and ECG phenotypes of LQT3 and BrS arise from biophysical
abnormalities of cardiac Na
+ channel function. In general, LQT3
is caused by a gain of channel function while BrS is caused by a
loss of channel function [6,7]. Distinct cardiac phenotypes caused
by SCN5A mutations have been described, including atrial
fibrillation [8], sick sinus syndrome (SSS), conduction disorders
such as atriventricular (AV)-block, and several more complex
phenotypes [9–11], Dilated cardiomyopathy (DCM) is character-
ized by dilated cardiac chambers and reduced systolic function,
which causes congestive heart failure. Patients with a family
history of DCM account for approximately 20 to 25% of
idiopathic DCM cases [12,13].
Since it was first linked to the SCN5A gene in 1996 [14], DCM
has been shown to be caused by a number of SCN5A mutations,
including two frameshift mutations [15], a deletion mutation [16],
and six missense mutations (T220I [17], R225W [18], R814W
[15], A1180V [19], D1275N [15,20], and D1595H [15]). With the
exception of R814W, the other mutations have been associated
with complex clinical phenotypes, including SSS, AV-block, and
atrial and ventricular arrhythmias, as well as with divergent
biophysical alterations of Nav1.5 [21]. Although, all these
mutations are located on the voltage sensor [22], it is unclear
which molecular mechanism is involved in the pathogenesis of
DCM. Very recently, the well-known H558R polymorphism and
alternative splice variant (Q1077del) were implicated in conduc-
tion system disease and DCM phenotypes in patients carrying the
R222Q mutation in the SCN5A gene [23].
In the present study, we investigated a patient with a severe
mixed phenotype who presented with cardiac conduction disorder
PLoS ONE | www.plosone.org 1 May 2012 | Volume 7 | Issue 5 | e38331and DCM. We identified a novel Nav1.5 mutation (R219H) that
causes a proton leak through an alternative pathway unrelated to
the Na
+ pore.
Methods
Clinical evaluation
A detailed clinical history, a 12-lead ECG, a transthoracic ECG,
and electrophysiological results were obtained at the initial
assessment of the index patient. At the follow-ups, repetitive
ECGs, Holter ECGs, echocardiograms, and stress-exercise tests
were performed. Detailed clinical histories, 12-lead ECGs, and
echocardiograms were obtained from the other family members.
Molecular genetics
The index patient and family members provided written
informed consent to participate in the study protocol, which was
approved by the ethics committee of the University Hospital of
Basel, Basel, Switzerland. Genomic DNA was extracted from
whole blood samples. All SCN5A coding exons were amplified by
polymerase chain reaction (PCR) using primers designed with
intronic flanking sequences [24]. Denaturing high performance
liquid chromatography (DHPLC) was performed on the DNA
amplification products using at least one temperature condition.
Products with abnormal DHPLC profiles were sequenced on both
strands of the exon using a big dye termination mix and an
automated laser fluorescent DNA sequencer (ABI Prism 377,
Applied Biosystems). PCR and direct sequencing were used to
identify the specific mutation in the family members. The
mutation was absent in 200 control chromosomes. The sequence
for the proximal connexin40 (Cx40) promoter in exon 1 carries
GenBank accession number AF246295. Polymorphisms in the
sequences upstream from Cx40 were genotyped by direct
sequencing of PCR products generated using the forward primer
59-TGAGGACAAGGACAACAGGCAG-39 and the reverse
primer 59-CCTTCCTCTGGCTACTTCATATC-39. The se-
quence for the coding region of Cx40 in exon 2 carries GenBank
accession number AF151979. PCR products generated with the
forward primer 59-TGGAATCCCAGAACATGATAGA-39 and
the reverse primer 59-TCAGTTCAGAAGGGAACAGTCT-39
were directly sequenced.
Na
+channel mutagenesis
We used a cDNA construct encoding the human Nav1.5 Na
+
channel [1]. Mutations were generated using QuikChange TM
site-directed mutagenesis kits according to the manufacturer’s
instructions (Stratagene). Oligonucleotide primers containing the
corresponding mutations were synthesized using the following
sequences:
For Nav1.5/R219H
59-C AAT GTC TCA GCC TTA CAC ACC TTC CGA GTC
CTC-39 (forward primer)
59- GAG GAC TCG GAA GGT GTG TAA GGC TGA GAC
ATT G-39 (reverse primer)
For Nav1.5/C373F
59-CCTGATGACGCAGGACTTCTGGGAGCGCCTC-
TAT C-39 (forward primer)
59-GATAGAGGCGCTCCCAGAAGTCCTGCGTCAT-
CAGG-39 (reverse primer)
For Nav1.5/R219A
59-CAATGTCTCAGCCTTAGCCACCTTCC-
GAGTCCTC-39 (forward primer)
59-GAGGACTCGGAAGGTGGCTAAGGCTGAGA-
CATTG-39 (reverse primer)
For Nav1.5/R219C
59-CAATGTCTCAGCCTTATGCACCTTCC-
GAGTCCTC-39 (forward primer)
59-GAGGACTCGGAAGGTGCATAAGGCTGAGA-
CATTG-39 (forward primer)
For Nav1.5/R219Q
59-CAATGTCTCAGCCTTACAGACCTTCCGAGTCCTC-
39 (forward primer)
59-GAGGACTCGGAAGGTCTGTAAGGCTGAGA-
CATTG-39 (forward primer)
The codons are underlined, and the base changes are indicated
in bold. The entire gene of each mutation was sequenced to check
for undesirable mutations.
Construct generation
Mutant and wild-type Nav1.5 Na
+ channels were inserted in
pPol1 [25], an oocyte expression vector containing theT7
promoter (59 to 39), the Xenopuslaevisb-globin 59-untranslated
region, a multiple cloning site, the Xenopus laevis b-globin 39-
untranslated region, a polyA tract, and a linearizing site. They
were amplified in E. coli XL2 Blue (Stratagene) and purified using
Genelute HP plasmid maxiprep kits (Sigma). The construct was
linearized with NotI, and T7 RNA polymerase was used to make
sense RNA using mMESSAGE mMACHINE T7 kits(Ambion).
Xenopus oocytes
All experimental procedures involving Xenopus oocytes were
approved by the Universite ´ Laval Institutional Animal Care
Committee in line with the principles and guidelines of the
Canadian Council on Animal Care (Approval 2011155-1), and
were prepared as described previously [26]. Briefly, the oocytes
were treated with 2 mg/ml of collagenase for 2 h. Stage IV or V
oocytes were selected and were microinjected with capped mRNA
coding for either the wild-type (WT) or mutant Nav1.5 channel
(1 mg/mlo fa-subunit and 0.3 mg/mlo fb1-subunit, 50 nl/oocyte)
or were mock injected with 50 nl/oocyte of sterile water. The
oocytes were incubated at 18uC in oocyte recipe 3 (OR3) medium
composed of a 1:2 dilution of Leibovitz’s L-15 medium
(Invitrogene) supplemented with 15 mM 4-(2-hydroxyethyl)-1-
piperazine-methanesulfonic acid (HEPES, pH 7.6, adjusted with
NaOH), 1 mM glutamine, and 50 mg/ml of gentamycin. [26] They
were used 3–4 days after injection. Macroscopic currents from the
mRNA-injected oocytes were recorded using either the voltage-
clamp technique with two 3 M KCl-filled microelectrodes or the
cut-open oocyte technique [27]. The membrane potential for the
two-microelectrode voltage-clamp technique was controlled using
a Warner oocyte clamp (Warner Instrument Corp.). The currents
were filtered at 2 kHz (23 dB; 4-pole Bessel filter). For
experiments using chloride-free solution, the headstage of the
Warner amplifier was attached to a plastic pool containing a 3 M
NaCl solution through a silver chloride wire connected to the bath
solution using an agar bridge containing 3% agar, 500 mM N-
methyl-D-glucamine (NMDG), and 10 mM HEPES (pH 7.4) and
threaded with a thin platinum/iridium wire to increase electrical
conductivity. The voltage for the cut-open oocyte technique was
controlled using a CA-1B amplifier (Dagan Corporation) and
mainframe clamp circuitry. The oocyte membrane was permea-
bilized using 0.1% saponin to provide low-resistance electrical
access to the intracellular environment, perfuse the intracellular
content, and remove chloride and potassium ions. Ca
2+ was
chelated with ethylene glycol tetraacetic acid (EGTA). Six agar
bridges were used as electrical connections, and were fabricated as
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using pCLAMP software version 10.0 (Molecular Devices).
Currents were filtered at 5 kHz (23 dB; 4-pole Bessel filter).
pHi measurements and electrode calibration
Intracellular pH (pHi) was measured using pH-sensitive
electrodes. Briefly, borosilicate glass capillaries (Harvard Appara-
tus) were pulled using a Sutter Puller (Sutter Instruments Co.) and
silanized with dichlorodimethylsilane ($99.5%, Sigma) for 20 min
in 5% (v/v) chloroform. After silanization, <0.5 mlo fN 1N1-
dimethyltrimethylsilylamine proton exchange resin (Fluka) was
placed in the tips of the capillaries using a 10-ml microsyringe
(Hamilton). The capillaries were backfilled with Ringer’s solution
and were calibrated using different pH solutions before and after
each experiment. The capillaries were then mounted on a holder
with an Ag-AgCl pellet attached to the high-impedance amplifier
of a two-channel FD223a electrometer (World Precision Instru-
ments). Electrodes that did not match the specifications of the resin
manufacturer (25761 mV/pH unit) were discarded. In some
experiments where pHi and proton currents were measured
simultaneously under voltage clamp conditions, the oocytes were
impaled with three electrodes, two standard microelectrodes for
the voltage clamp and one containing the pH resin. A common
reference electrode was used for both amplifiers.
Solutions and reagents for Xenopus oocytes
The Ringer’s bathing solution was composed of 116 mM NaCl,
2 mM KCl, 2 mM CaCl2, 2.9 mM MgCl2, and 5 mM HEPES.
The pH was adjusted to 7.4 at 22uC using 1 M NaOH. The
external chloride-free solution was composed of 120 mM N-
methyl-D-glucamine (NMDG), 2 mM CaCl2, and either 20 mM
TRIS (trishydroxyme ´thylaminome ´thane) (pH 8.4–8.6), 20 mM
HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic
acid)(pH 7.4 to 6.8), or 20 mM MES (2-(N-morpholino) ethane-
sulfonic acid) (,pH 6.8). The NMDG solutions were adjusted to
the desired pH using methanesulfonic acid (Sigma). The intracel-
lular NMDG solution was the same as the external solution for the
cut-open oocyte technique except that the CaCl2 was replaced
with 10 mM EGTA. All the recording solutions had an osmolarity
of 240–260 mOsm. All the chemicals and drugs were purchased
from Sigma except for tetrodotoxin, which was purchased from
Latoxan (Valence, France). All the experiments were carried out at
room temperature (<22uC).
Data analysis and statistics
The electrophysiological data was analyzed using macros in
Campfit (pCLAMP v10.0, Molecular Devices) and custom
programs written using MATLAB (The MathWorks Inc.).
Statistical tests were performed using SigmaPlot 11(Systat Soft-
ware Inc.). The results are expressed as means 6 standard errors
of the mean (SE). The number of measurements (n) is indicated in
parentheses. Statistical comparisons were performed using an
unpaired Student’s t-test or Mann-Whitney’s rank sum test.
Differences were deemed significant at p,0.05. The p values are
indicated in the text or figure legends.
Results
Clinical phenotypes of the index patient and the family
members
The index patient was a 29-year old man in a three-generation
family (Figure 1A), who presented with a four-day history of
epigastric pain and dizziness. The clinical examination revealed
bradycardia (43 bpm), and a 12-lead ECG showed a third degree
AV-block with a ventricular escape rhythm, narrow QRS
complex, and ventricular premature depolarizations (Figure 1B).
Transthoracic echocardiography showed mild dilated cardiomy-
opathy with dilation of both atria and ventricles (left at-
rium=43 mm, left ventricular end diastolic diameter
(LVEDD)=62 mm), with mildly decreased left ventricular ejec-
tion fraction (LVEF=49%) and moderately decreased right
ventricular systolic function (see echocardiogram in Figure
S1). Acute coronary syndrome was excluded by repetitive negative
troponins. A cardiac MRI revealed no signs of myocarditis or
sarcoidosis and confirmed echocardiographic findings. A cardiac
biopsy revealed unspecific findings. PCRs for common myocarditis
infections were negative (e.g., enterovirus, parvovirus, herpes virus,
Epstein Barr virus, adenovirus, cytomegalovirus, and Borreliaburg-
dorferi). A clinical electrophysiological study revealed a first degree
AV block with intermittent third degree AV block, delayed A–H
conduction (145 ms), a normal H-V-interval (45 ms), and no
inducible ventricular tachycardia. A DDD pacemaker was
implanted, and a combinational treatment with an ACE-inhibitor
(perindopril) and indapamid was started. During a 3 monthsfollow
up, the patient showed intermittent sinus rhythm whereas mild
DCM was persistent with slightly decreased LVEF (52%). Eleven
months later, during a bicycle exercise stress test (EST), the patient
developed non-sustained ventricular tachycardia (220 bpm) at a
heart rate of 130 bpm and a work load of 192 W (Figure 1C). A
bisoprolol (10 mg/d) treatment was initiated. The follow-up EST
with a maximal work load of 235 W and a maximum heart rate of
129 bpm showed no ventricular arrhythmias. Two months later,
the patient was admitted to the hospital with atrial flutter (Figure
S2). Immediate radiofrequency ablation of the atrial flutter was
successfully performed. During further follow-up, the patient
developed non-sustained ventricular tachycardia (Holter-ECG),
and a cardioverter defibrillator was successfully implanted.
The family history revealed DCM in the patient’s mother (II-2)
and in three of the mother’s sisters (Figure 1A). A transthoracic
echocardiogram of the mother revealed a mildly dilated left atrium
and a dilated left ventricle (LVEDD 57 mm), with mildly
decreased systolic function (LVEF 48%). She suffered from
frequent monomorphic premature ventricular contractions
(PVC), but never revealed any episodes of atrial flutter, fibrillation
or ventricular tachycardia. In the three sisters of the mother,
echocardiography revealed the same echocardiographic pheno-
type with mild DCM; they all complained about infrequent PVC.
The older sister (III-2) of the index patient was diagnosed with
borderline DCM, suffering from frequent PVC.
Identification of a novel SCN5A mutation and family
screening
DCM has been reported to be caused by a number of SCN5A
mutations [21]. We identified a novel SCN5A mutation in the
index patient. DHPLC (Figure 1D) and sequencing revealed a
heterozygous change of CGC arginine (R) to CAC histidine (H),
which resulted in the missense mutation R219H (Figure 1E). The
family screening identified the mutation in the mother (II-2) and
the patient’s sister (III-2) (Figure 1A). The mother’s three sisters
with DCM (II-3, II-4, and II-5) refused genetic testing. The
mutation was located in the S4 segment of the Nav1.5 voltage-
sensor domain. This arginine residue is highly conserved in the
voltage-sensor domain of ion channels in humans, squid
(Figure 1F), and other species. Since it has been reported that
an SCN5A DCM mutation (D1275N) can co-segregate with two
connexin40 (Cx40) polymorphisms [20,28], we sequenced the
codons of these polymorphisms as well as the upstream regions
A Proton Leak through Cardiac Na+ Channels
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(Figure S3).
In addition, the H558R polymorphism is not present in the
genotyped family members and the Q1077del splice variant was
without effect on the proton current (data not shown).
Nav1.5/R219H does not change the biophysical
properties of Na
+ channels expressed in Xenopus
oocytes and tsA201 cells
Robust Nav1.5 Na
+ currents were recorded from both WT and
R219H mutant channels using the cut-open Xenopus oocyte system.
They exhibited a typical pattern of rapid voltage-dependent
activation and inactivation kinetics (Figure 2A–B). The peak
currents for the WT and R219H channels were plotted as
normalized conductance-voltage (G–V) curves (Figure 2C). No
significant differences between the WT and R219H channels were
observed. Steady-state inactivation showed no alterations in the
best-fit parameters for both the slope and midpoint of inactivation
(Figure 2C and Table S1). No significant effects were observed
for recovery from fast inactivation (Figure 2D and Table S1).
The patch clamp studies using the tsA201 mammalian expression
system corroborated the Xenopus oocytes experiments (Figure
S4A–F and Table S2). The methods for the patch clamp
experiments could be found in Figure S4 legend.
The R219H mutant Na
+ channel conducts an inward pH-
dependent current at hyperpolarizing voltages
The nature of the R to H amino acid substitution and its
involvement in generating proton leaks in Shaker and Nav1.4 ion
channels prompted us to verify whether the mutant channels leak
H
+ ions [29,30]. We used the Xenopus oocyte system because it
allows the expression of high levels of Na
+ channel proteins. This
system also circumvents many limitations of HEK293 mammalian
cells such as the presence of ASIC channels that are sensitive to
extracellular pH variations. [31]
Figure 1. Family pedigree, clinical evaluation, and molecular genetics. (A) The index patient (III-1) is indicated by an arrow. Individuals
indicated with black squares/circles carry the mutation and a clinical phenotype (III-1, III-2, II-2). Individuals indicated with grey circles (II-3 to II-5) were
clinically diagnosed with DCM, but not genotyped. Abbreviation: DCM (dilated cardiomyopathy). (B) 12-lead ECG of the index patient showing third
degree AV-block with a ventricular escape rhythm and a small QRS-complex with a heart rate of 43 bpm (artefact in lead V1). (C) Non-sustained
ventricular tachycardia (220 bpm) occurred at a heart rate of 130 bpm and a work load of 192 W during an exercise stress test. (D) Different DHPLC
eluting profiles at 59.8uC of the PCR products of exon 6 in the index patient compared to the control. Abbreviation: DHPLC (denaturing high
performance liquid chromatography). (E) A heterozygous change of arginine CGC (R) to histidine CAC (H) resulted in the missense mutation R219H.
(F) Sequence alignments of the S4 of domain 1 from Na
+ and K
+ (Shaker B) channels in different species.
doi:10.1371/journal.pone.0038331.g001
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inset), we changed the extracellular pH (pHo) and observed an
increased inward current that was several hundred nA in
amplitude when the pHo of the Ringer’s solution was reduced
from 7.40 to 6.80 or lower for oocytes expressing the Nav1.5
mutant channel (Figure 3A). This pH-dependent inward current
was not affected by TTX (1 mM), a selective pore blocker of
voltage-gated Na
+ channels (Figure 3B), indicating that the
inward current pathway in mutant channels differed from that of
the channel pore.
To distinguish this leak current from the alpha current (pore of
the channel), Na
+ ions were substituted by NMDG. No chloride
ions were added in order to reduce chloride current contamina-
tion. In a Na
+-free NMDG solution, mutant Na
+ channels
displayed a significantly increased inward current at pHo 7.40
and lower (Figure 3C). However, an acidic external pH did not
induce a current in WT-injected or water-injected oocytes
(Figure 3C top panels). The inward current increased as the
pHo become more acidic, and the effect was reversible
(Figure 3c). The pH-dependent inward current was fully
reversible (Figure 3D). To elucidate the specific role of the
histidine at position 219, we created a series of mutants by
replacing R219 with alanine, glutamine, lysine, or cysteine. Acidic
pHo values did not induce an inward current in these mutants
(Figure S5A–D).
The pH-dependent inward current is a H
+ current
We used an H
+-selective electrode to directly measure
intracellular pH and to test the hypotheses that this inward
current is a proton current and that the protons conducted
through the mutant channel can induce intracellular acidification.
We simultaneously recorded currents using a two-microelectrode
technique in Na
+-free NMDG solution in the presence of 1 mM
TTX as indicated in Figure 4A. Inward currents paralleled
intracellular acidification, especially at lower pHo (6.80–6.00)
values. This suggested that the inward current observed is a proton
current and that it causes intracellular acidification. This effect was
not affected by 1 mM TTX and was partially reversible
(Figure 4A). No current was detected and no acidification was
observed in Nav1.5/WT-injected oocytes (Figure 4B). Figure 4C
shows the degree of intracellular acidification at different pHo
values in oocytes expressing WT or R219H mutant channels and
in water-injected oocytes.
We also measured the pHi to determine whether proton
currents flowing through the mutant channel contribute to
intracellular acidification at rest. Oocytes expressing WT or
R219H channels as well as water-injected oocytes were incubated
in OR3 medium (see methods) for 18 h at different pHo values and
were transferred into the recording chamber. pHi was measured
using a pH-sensitive electrode. The incubation of the oocytes at
acidic pHo values resulted in significant intracellular acidification,
unlike the slight acidification observed with oocytes expressing WT
channels and with water-injected oocytes (Figure 4D). This
suggested that there may be a flow of H
+ ions into cardiac
myocytes at the resting potential (280 mV).
The voltage-dependence of the proton current was recorded
using 10 mV voltage steps from 2140 mV to +40 mV from a
holding potential of 280 mV (Figure 5A). The proton current
was pHo-dependent, was higher at more hyperpolarizing voltages
(Figure 5A), and exhibited a voltage-dependent inward rectifica-
tion that occurred near 250 mV at pHo 7.40 (Figure 5B). This is
the voltage at which the voltage sensor (shown by measuring the
Q–V curve representing the gating-charge movement), and thus
Figure 2. Biophysical characterization of the Nav1.5/R219H
DCM mutation proton current recordings. Representative current
traces recorded using the cut-open oocyte technique from Nav1.5/WT
(A)a n dN a v1.5/R219H (B) channels. Currents were elicited by
depolarizing pulses from 2100 mV to +60 mV, with 10 mV increments
for each step. (C) The voltage dependence of steady-state activation
and inactivation of WT (activation, n=7; inactivation, n=8) and R219H
(activation, n=8; inactivation, n=8). Activation curves were derived
from I–V curves and fitted to a standard Boltzmann equation: G (V)/G
max=1/(1+exp ((V2V1/2)/kv)), with midpoints (V1/2) is slow factors (kv)
listed in Table S1. The voltage-dependence of inactivation was
induced by applying conditioning pre-pulses to membrane potentials
ranging from a holding potential of 2150 to 220 mV for 500 ms with
10 mV increments and was then measured using a 20-ms test pulse to
230 mV for each step (see protocol in inset). The recorded inactivation
data were fitted to a standard Boltzmann equation: I (V)/Imax=1/(1+exp
((V2V1/2)/kv)), with midpoints (V1/2) is slow factors (kv) listed in Table
S1.( D) Time courses of recovery from inactivation of Nav1.5/WT and
Nav1.5/R219H channels. A 40 ms conditioning pre-pulse was used to
monitor recovery using a 20-ms test pulse after a variable recovery
interval ranging from 5 to 500 ms (see protocol in inset). A single-
exponential function was used to determine the time constants of
recovery.
doi:10.1371/journal.pone.0038331.g002
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+
permeation pathway.
The reversal potential was measured to determine whether the
observed current was selective for H
+(Figure 5B). We measured
the pHi using a pH-sensitive electrode while recording inward
currents. Voltage steps were applied from a holding potential of
280 mV, and ranged from 2140 mV to +40 mV. To ensure that
the reversal potential could be measured, a more basic extracel-
lular pH (pHo8.40) was used, keeping in mind an important
constraint that, at pHo,7.40, the expected reversal potential is
more depolarized than 250 mV. More positive potentials than
250 mV reflect a situation in which S4 voltage sensors are
predicted to be stabilized in an upward position, resulting in a
decrease in the H
+ current. These measurements were made with
oocytes in which the expression of Na
+ channels was very high and
in which currents could be detected at pHo 8.40. Figure 5B (filled
circles) shows a reversal potential measured using pH-sensitive
electrode in an oocyte expressing Nav1.5/R219H where the pHi
was 6.90. The observed reversal potential (<290 mV) was close
to the predicted value calculated using the Nernst equation
(EH=RT/zF*ln [Ho]/[Hi]=288.9 mV) and was consistent with
a highly-selective H
+ current.
The proton current increased in tandem with the expression of
the Na
+ channels with a significant correlation (R
2=0.93) and
made up 5% of the peak Na
+ current (Figure 5C), suggesting that
the a subunit was responsible for the proton current.
The histidine residue was titrated to confirm its involvement in
generating proton currents. The titrated curve generated by
plotting the pHo values against the proton current amplitude
measured at 2140 mV fit well with the Henderson-Hasselbach
equation (Figure 5D). The measured pKa was 6.4860.01 (n=5),
which was in agreement with the pKa of the histidine in an
aqueous solution (pKa=6.5).
Discussion
Clinical aspects of the DCM patient
Human molecular genetic studies have uncovered over 30
distinct genes linked to the pathophysiology of DCM [32,33].
While it is known that SCN5A mutations are involved in
ventricular arrhythmia, the same cannot be said for structural
Figure 3. Nav1.5/R219H exhibits a pH dependent current. Panel (A) shows that varying the Ringer’s extracellular pH (pHo) induced an inward
current in Nav1.5/R219H–injected oocytes. An acidic Ringer’s solution induced inward currents in an oocyte expressing the Nav1.5/R219H channel.
The oocyte was held at 280 mV and a 2140 mV test pulse was repeated every 2 s (only current responses at 2140 mV are shown). The bottom
panels show current traces of the experiment in (A). The inset shows the protocol, and the grey zone indicates where currents were measured as a
mean of the current amplitude between 150 and 200 ms.(B) Effect of an acidic Ringer’s solution in the presence of TTX in an oocyte expressing the
Nav1.5/R219H mutant channel in a background in which the native cysteine in D1 had been replaced with a tyrosine (C373F) and in the presence of
1 mM TTX. This mutation in the pore region increases the TTX sensitivity of cardiac channels 60- to100-fold, as described previously [46]. (C) Currents
recorded from a water-injected and oocyte expressing the Nav1.5/WT or Nav1.5/R219H channel. The oocytes were held at 280 mV and were pulsed
to 2140 mV. This protocol was repeated every 2 s as indicated in the inset (panel A). Acidic NMDG solutions induced a pH-dependent current in an
oocyte expressing the Nav1.5/R219H channel in a C373F background in the presence of 1 mM TTX. This experiment was carried out in a Nav1.5
background in which the native cysteine in D1 was replaced with a tyrosine (C373F). (D) Acidic NMDG solutions induced a reversible current in an
oocyte expressing the Nav1.5/R219H channel.
doi:10.1371/journal.pone.0038331.g003
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members were genotyped and were found to carry the R219H
mutation. They showed a robust genotype-to-phenotype correla-
tion, suggesting that the DCM was strongly associated with the
R219H mutation. No co-segregation of R219H with two
nucleotide polymorphisms inthe regulatory region of Cx40
(244AA, +71GG), which has been reported to reduceCx40
expression levels that could contribute to the atrial electrical
abnormalities, was found [28]. This suggests that R219H was the
main mutation causing atrial electrical disturbances associated
DCM. Additional DCM or arrhythmia genes were not screened
for mutations as SCN5A was considered the target gene for the
mixed cardiomyopathy-arrhythmia phenotype. The same muta-
tion was reported in a Japanese family with Sick sinus syndrome
[34]. For unknown reasons the mutation did not express in these
authors hand. In our hand this mutation was fully functional.
Biophysical properties of R219H channels
The basic biophysical properties (activation, inactivation,
recovery from inactivation, and kinetics) of the mutated channels
expressed in either Xenopus oocytes (Figure 2) or the tsA201
mammalian cell line (Figure S4) were not altered. Furthermore, no
persistent Na
+ current could be detected (data not shown).
While several Nav1.5 mutations have been identified in patients
with DCM that may contribute to the disease, the molecular
mechanisms underlying their involvement are poorly understood.
It is difficult to explain such clinical phenotypes solely on changes
in the electrical properties of cardiac sodium channels.
Figure 4. Nav1.5/R219H induces an inward proton current and intracellular acidification. Xenopus oocytes expressing Nav1.5/WT or
Nav1.5/R219H channel were impaled with three electrodes, one filled with an H
+ resin to measure pHi, and two to clamp the oocyte at 280 mV in a
Na
+-free NMDG solution containing 1 mM TTX, as indicated. Typical proton current recordings (red traces) in response to different pHo value and the
pHi measurement rate (bleu traces) from an oocyte expressing the Nav1.5/R219H (A)o rN a v1.5/WT channel (B). Intracellular pHi values before
changing solutions in experiments similar to (A) and (B) were plotted against pHo (***, p,0.001 compared to WT, n=10–19)(C). Similar recordings
were obtained with four batches of oocytes. (D) Changes in pHi after incubating oocytes expressing the Nav1.5/WT (triangles) or Nav1.5/R219H
(squares) channel, or water-injected oocytes (circles) in OR3 medium at different pHo values (***, p,0.001, **; p,0.01; *, p,0.05; compared to WT,
n=7–13). pHi measurements were carried out in Ringer’s solution at pHo of 7.40.
doi:10.1371/journal.pone.0038331.g004
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current that is a H
+ current
We tested the hypothesis that mutant channels may leak H
+ and
are thus sensitive to changes in extracellular pH. Titrating
histidine at pHo 7.40 and above resulted in a reversible inward
H
+ current at hyperpolarized voltages, in contrast to water-
injected oocytes and WT Nav1.5-injected oocytes in which no
current was generated. Furthermore, the H
+ current was not
affected by 1 mM TTX. These findings indicated that the inward
H
+ current is TTX-insensitive and, more importantly, that H
+
protons do not leak into the cell through the Na
+ ion permeation
pathway but through an alternative pathway. In addition, the
current was activated by hyperpolarizing voltages at which there is
very little if any likelihood of the a pore opening.
We used H
+-selective electrodes to determine whether the H
+
protons conducted through the mutant channel induced intracel-
lular acidification. We simultaneously recorded H
+ currents using
a two microelectrode technique in Na
+-free condition. Inward H
+
currents paralleled intracellular acidification, especially at more
acidic pHo values (6.80 and 6.00), suggesting that the inward
current observed was indeed an H
+ current that caused
intracellular acidification
Similar H
+ channels can be formed by replacing the most
positively charged arginine residue of the Drosophila Shaker voltage-
Figure 5. Proton current-voltage relationship of the Nav1.5/R219H channel recorded in an NMDG Na
+-free solution.(A) Representative
proton current traces from oocytes expressing the Nav1.5/R219H channel recorded at pHo 8.40, 7.40, 6.80, and 6.00, as indicated, in response to
200 ms voltage steps ranging from 2140 mV to +40 mV in 5-mV increments from a holding potential of 280 mV (the protocol is given in the centre
inset), without on-line leak subtraction. The dashed line represents the zero current. For clarity, only current every 10 mV are shown. (B) Current-
voltage relationship where the currents in (A) were plotted as a function of the test potential (5 mV increments), after offline linear leak subtraction.
Reversal potential determined in a Na
+-free NMDG solution at pHo 8.40 using voltage steps as described in (A). The pHi was measured using a pH-
sensitive electrode. Similar results were obtained with four separate batches of oocytes. The inset shows the pHoand pHi values and between
parentheses is the predicted values calculated using the Nernst equation. The bleu trace shows the voltage-dependent of activation (Q–V), the grey
zone illustrates the transitional zone corresponding to the probability of the voltage sensor being stabilized in the outward position. (C) Correlation
between the peak Na
+ current measured in Ringer’s solution and the proton current measured at 2140 mV and pHo 4.00 (n=31) on the same
oocytes. The data were obtained from one batch of oocytes over three days. The straight line represents the linear regression of the data set and R
2 is
the correlation coefficient and shows the goodness of fit. Similar results were obtained with three separate batches of oocytes. (D) Proton currents
measured in response to a change in pHo at 2140 mV in an NMDG Na
+-free solution. The currents were normalized to the currents obtained at
pHo=4.00 for each cell. The mean data (n=5) was fitted to the Henderson-Hasselbach equation, 1/[1+exp(2.3(pHo2pKa))]. Error bars are smaller than
the symbols.
doi:10.1371/journal.pone.0038331.g005
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+ channel with a histidine [29]. Recent studies have
associated similar leak currents through the v pore of Nav1.4, the
skeletal muscle Na
+ channel, with hypokalemic periodic paralysis
[30,35]. The extent to which this pore also allows H
+ permeation
requires further investigations.
Nav1.5/R219H generated a proton current, even in the
presence of 300 mM amiloride at acidic pH values (data not
shown), suggesting that amiloride-sensitive channels and H
+
transporters do not contribute to this current and that amiloride
does not inhibit this current. We tested several potential blockers,
including Ni
2+,C d
2+,Z n
2+,L a
3+, and ethylguanidine, none of
which inhibited this current at millimolar concentrations (data not
shown).
Proposed mechanisms for proton permeation
Replacing the arginine residue with a histidine revealed a
permeation pathway across the voltage sensor domain of Nav1.5
Na
+ channel, most probably via a proton wire route, through
which H
+ translocates into the cell in a way similar to what has
been proposed for gramicidin-A channels and Shaker potassium
channel [29,36]. Proton conduction through gramicidin-A chan-
nels has been described as occurring via a hop-and-turn
mechanism. This mechanism involves H
+ ion hops between water
molecules, which account for the high H
+ selectivity observed. The
proton current-voltage relationship of R219H exhibited strong
voltage-dependent rectification (Figure 5B), which occurred near
250 mV (pHo of 7.40). At more depolarized voltages, the voltage
sensors are more stabilized in an outward position and thus disrupt
the proton wire. The permeation pathway may thus be favoured
by the inward position of the D1S4 helix at hyperpolarized
voltages (,250 mV) and may be blocked when the S4 helix
moves outward (.0mV), with a transition zone between 250 and
0 mV in which the probability of this movement taking place
increases (Figure 5B, grey zone), thus disrupting the proton
wire [37,38].
Pathophysiology
A proton current through mutated cardiac Na
+ channels can
depolarize cardiac myocytes and make the resting membrane
potential unstable and thus contribute to premature ventricular
depolarizations. H
+ leaking into cardiac myocytes may disrupt pHi
homeostasis and transform the proton leak into a Na
+ leak, leading
to intracellular Na
+ accumulation via the activation of H
+
transporters, including the Na
+-H
+ anti-port exchanger [39].
The increase in Na
+ can lead to Ca
2+ accumulation via the reverse
mode of the Na
+/Ca
2+ exchanger [40], which may modify
calcium homeostasis and lead to changes in the contractile
properties of the myocyte [41]. The accumulation of Ca
2+ may
also have a deleterious effect and may contribute to DCM
phenotypes. It is also likely that acidosis directly affects myofila-
ment sensitivity to Ca
2+, which has been reported previously to
reduce the affinity of troponin C for Ca
2+ and thus impair
excitation-contraction coupling [42]. These ionic homeostatic
alterations, including acidification, may also directly or indirectly
(e.g., via phosphorylation status) uncouple gap junctions, as already
suggested for Cx40 [43] and Cx43 [44]. Acidification is also
deleterious for gap junction integrity [45]. The sensitivity of
cardiac connexins to acidification probably contributes to the
diverse conduction disturbances and arrhythmias seen in our
patient. Future research using a cellular model (stem cells) or an
animal model reproducing the R219H mutation (knock-in mice) is
warranted.
Our study revealed an unexpected, but pathologically signifi-
cant, proton current associated with the cardiac Na
+ channel. This
novel proton leak current is essentially a gain-of-function because
it induces an H
+ leak that is not present when arginine occupies
position 219. It may thus cause DCM and complex electrical
phenotypes. It is noteworthy that heart failure therapy with a beta-
blocker and perindopril/indapamid controlled the progression of
DCM in our patient. The ideal pharmacological strategy would be
to inhibit the H
+ leak without affecting normal channel gating and
Na
+ permeability.
Supporting Information
Table S1 Biophysical properties of Nav1.5/WT and
Nav1.5/R219H obtained using the cut-open oocyte
technique.
(DOC)
Table S2 Biophysical properties of Nav1.5/WT and
Nav1.5/R219H obtained using the patch clamp tech-
nique.
(DOC)
Figure S1 Echocardiogram of the index patient’s heart.
Apical four chamber view showing dilation of both atria and
ventricles with mildly decreased left and moderate decreased right
ventricular systolic function: LVEDD 59 mm, LVESD 50 mm,
IVSd 10 mm, PWd 8 mm, LA 48 mm, LVEF 50%. EDV 236 ml,
EDVI 118 ml/m2. LVEDD: left ventricular end-diastolic diam-
eter; LVESD: left ventricular end-systolic diameter; IVSd: inter-
ventricular septum diastolic; PWd: posterior wall diastolic; LA: left
atrium, LVEF: left ventricular ejection fraction; EDV(I): End-
diastolic left ventricular volume (Index).
(TIF)
Figure S2 12-lead ECG showing atrial flutter with 3:1
conduction on the index patient.
(TIF)
Figure S3 Connexin40 genotyping. To investigate whether
the Nav1.5/R219H could co-segregate with the already reported
Cx40 polymorphisms
1, we sequenced the entire coding region of
Cx40 and Cx40 upstream sequences, in the mother the father and
the two siblings. Although the mother and her son were
phenotypically (DCM) and genotypically (R219H) similar, they
differ in polymorphisms on Cx40 upstream sequences proposed to
change Cx40 expression levels. The mother (patient II-2) was
homozygote [244AA (a), +71GG (b)), conditions where the
expression of Cx40 is markedly reduced
1]. However, the index
patient (patient III-1) was heterozygote at both positions
[244AG and +71AG]. Groenewegen, W.A. et al. A cardiac
sodium channel mutation cosegregates with a rare connexin40
genotype in familial atrial standstill. Circ. Res. 92, 14–22 (2003).
(TIF)
Figure S4 Biophysical characterization of Nav1.5/
R219H Na
+ channels expressed in tsA201 cells. Represen-
tative current traces recorded from Nav1.5/WT (a) and Nav1.5/
R219H (b). Currents were elicited by depolarizing pulses starting
at 2100 mV to +50 mV with a 10 mV increment for each step
from a holding potential of 2140 mV, as shown in the inset
protocol. (c) Current-voltage relationship of WT and R219H.
Current amplitude was normalized to the membrane capacitance
to generate the corresponding current density. (d) The activated
and inactivated currents were generated from the protocols as
inset. Using the same data as (c) and graphically determined
reversal potentials (Erev), the Na
+ conductance (G) for the various
voltages was calculated from the equation G=I/(V2Erev). The
fraction of the conductance was obtained by normalizing the
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Steady-state inactivation was measured by applying 500 ms pre-
pulses ranging from 2140 to 250 mV, followed by a 20 ms test
pulse at 230 mV. The resulting data of steady-state activation and
inactivation were fitted to a standard Boltzmann distribution. (e)
Slow inactivation in WT and R219H. A two-pulse protocol as
inset was used to generate the currents. The course of slow
inactivation was assessed using a two-pulse protocol with an initial
conditioning pre-pulse and a final test pulse. A 230 mV pre-pulse
was applied at intervals varying from 1 to 1000 ms, followed by a
step to 2140 mV for 20 ms to allow the channels to recover from
fast inactivation. The 230 mV test pulse was applied for 40 ms to
estimate the fraction of channels available for activation. Time
constants (shown in Table S2) were obtained using a mono-
exponential function. (f) Time courses of recovery from slow
inactivation in WT and R219H. A 500 ms conditioning pre-pulse
was used to monitor recovery by a 20 ms test pulse after a variable
recovery interval from 1 to 1000 ms (see protocol in inset). A two-
exponential function was used to obtain the resulting time
constants (shown in Table S2). Results are presented as means
6 standard error. Methods Figure S4: TsA201 cells were grown in
high glucose Dulbecco’s modified Eagle’s medium (DMEM)
supplemented with fetal bovine serum (10%), L-glutamine
(2 mM), penicillin G (100 U/ml), and streptomycin (10 mg/ml)
(Gibco). The cells were incubated in a 5% CO2 humidified
atmosphere after being transfected with WT or mutant human
Nav1.5 cDNA (2 mg) and human b1-subunit (2 mg) using the
calcium-phosphate method. The human Na channel b1-subunit
and CD8 were inserted in the pIRES bicistronic vector in the form
of pCD8-IRES-b1. Using this strategy, transfected cells that bound
beads also expressed the b1-subunit protein. Transfected cells were
incubated in the medium containing anti-CD8-coated beads
(Dynal) for 2 min before performing patch-clamp experiments.
Cells expressing CD8 were distinguished from non-transfected
cells by visualizing beads fixed on the cell membrane by light
microscopy. Sodium currents recordings: The whole-cell configuration
of the patch clamp technique was used to record macroscopic Na
currents from transfected tsA201 cells. Patch clamp recordings
were obtained using low-resistance, fire-polished electrodes
(,1M V) made from 8161 Corning borosilicate glass coated with
Sylgard (Dow-Corning) to minimize electrode capacitance.
Currents were recorded with an Axopatch 200 amplifier
(Molecular), and series resistance was .80% compensated.
Command pulses were generated, and currents were acquired
using a Pentium-based computer running pCLAMP software v8.0
equipped with a DigiData 1300 AD converter (Molecular
Devices). P/4 leak subtraction was used to compensate for linear
leaks and eliminate capacitative transients. Currents were filtered
at 5 kHz and digitized at 10 kHz. All recordings were performed
at room temperature (22–23uC). Cells were permitted to stabilize
for 10 min after establishing the whole-cell configuration before
recording currents. A 7 mV junction potential between the patch
electrode and the bath solution was corrected. Solutions and reagents:
For the whole-cell recordings, the patch pipettes were filled with a
solution containing 35 mM NaCl, 105 mM CsF, 10 mM EGTA,
and 10 mM Cs-HEPES. The pH was adjusted to 7.4 using 1 N
CsOH. The bath solution consisted of 150 mM NaCl, 2 mM KCl,
1.5 mM CaCl2, 1 mM MgCl2, 10 mM glucose, and 10 mM Na-
HEPES. The pH was adjusted to pH 7.4 using 1 N NaOH (final
Na
+: 152.4 mM).
(TIF)
Figure S5 Effect of alanine, glutamine, lysine and
cysteine substitution. The arginine 219 was substituted with
alanine (a), glutamine (b), lysine (c) and cysteine (d), and oocytes
expressing mutant channels were superfused with Na
+-free
NMDG solution at different pHo. Proton currents were measured
every 2 seconds, using a hyperpolarizing pulse of 2140 mV from
a holding potential of 280 mV, as indicated in the inset. No
proton currents could be seen in the presence of all mutant
channels except for the cysteine mutant, where a slight inward
deflection of the current at extreme acidic pHo value (5.20) (d) was
observed, but we did not study this effect in greater detail. Similar
results were obtained in two separate batches of oocytes.
(TIF)
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